SpineX Introduces Novel SciP Device for the Treatment of Cerebral Palsy

SpineX has introduced novel SciP, a non-invasive spinal electrical neuromodulation device for the treatment of cerebral palsy (CP) in children.

SCiP being a non-invasive spinal electrical neuromodulation device, offers the potential for a safer and less intrusive treatment option compared to traditional surgical interventions.

The device's transcutaneous spinal cord stimulation aims to address the underlying neurological dysfunction in paediatric patients with CP, potentially transforming their brain and spinal cord connectivity into highly functional systems.

This non-surgical device has the potential to improve the lives of many individuals within the cerebral palsy community, offering a chance for better functional outcomes and increased quality of life.

SCiP will bring newfound hope and open up previously unexplored opportunities for families with children affected by cerebral palsy.

The positive results from early clinical feasibility studies are promising and indicate that SCiP has the potential to revolutionise the treatment of cerebral palsy in children. If successful, it could be a groundbreaking medical device and the first of its kind in the United States for this particular condition.

FDA has granted Breakthrough Device Designation for SCiP (Spinal Cord Innovation in Pediatrics), designed to potentially treat cerebral palsy (CP) in children.